At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 70 enrolled
Drug / intervention
AtriCure LAA Exclusion Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Exclusion of the Left Atrial Appendage With the AtriClip LAA Exclusion Device in Patients Undergoing Concomitant Cardiac Surgery
In Brief
A Phase 2 clinical trial evaluating AtriCure LAA Exclusion System for Left Atrial Appendage Exclusion. Completed, enrolled 70 participants across 7 sites.
Detailed Summary
Prospective, non-randomized trial to evaluate the safety and efficacy of the LAA Exclusion Device (Clip) for the exclusion of the LAA via epicardial tissue approximation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLeft Atrial Appendage Exclusion
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2008
First PostedOct 2008
Primary CompletionOct 2009
Study CompletionOct 2011
TodayJul 2026
First PostedOct 24, 2008
Enrollment StartSep 1, 2008
Primary CompletionOct 1, 2009
Study CompletionOct 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 17.7 years ago
Interventions
AtriCure LAA Exclusion Systemdevice
Exclusion of the left atrial appendage using the AtriCure LAA Exclusion System